Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis
Allergy2017Vol. 72(12), pp. 1825–1848
Citations Over TimeTop 1% of 2017 papers
Sangeeta Dhami, Αρτεμισία Κακούρου, Felix Asamoah, Ioana Agache, Susanne Lau, Marek Jutel, Antonella Muraro, Graham Roberts, Cezmi A. Akdiş, Matteo Bonini, Özlem Cavkaytar, Breda Flood, Paweł Gajdanowicz, Kenji Izuhara, Ömer Kalaycı, Ralph Mösges, Óscar Palomares, Oliver Pfaar, Sylwia Smolińska, Milena Sokołowska, Miqdad Asaria, G. Netuveli, Hadar Zaman, Ather Akhlaq, Aziz Sheikh
Abstract
AIT can achieve substantial reductions in short-term symptom and medication scores in allergic asthma. It was however associated with a modest increased risk of systemic and local AEs. More data are needed in relation to secondary outcomes, longer-term effectiveness and cost-effectiveness.
Related Papers
- → Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence(2012)179 cited
- → The allergen specificity of allergen immunotherapy—doubt no more(2019)9 cited
- → Update on Allergen Immunotherapy for Treatment of Allergic Diseases(2013)2 cited
- → Immunotherapy in the Age of Anti-IgE(2004)2 cited
- Allergen immunotherapy: the good, the bad, and the unknown.(2014)